Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$25.46 0.01 (0.04%) as of 4:30 Fri 5/17


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 1.55(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $25.45
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 10,000 1,687,666
Total Buy Value $0 $0 $138,828 $30,291,232
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 1 3
Total Shares Sold 0 75,715 115,161 179,650
Total Sell Value $0 $1,108,986 $1,602,723 $2,646,007
Total People Sold 0 5 6 6
Total Sell Transactions 0 14 25 43
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 290
  Page 5 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2021-02-16 4 S $48.87 $6,451 D/D (132) 37,286 20%     
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2021-02-16 4 A $0.00 $0 D/D 11,100 17,632     -
   Flynn Daniel Lee Chief Scientific Officer   •       –      –    2021-02-16 4 S $48.87 $24,826 D/D (508) 6,532 20%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2021-02-16 4 A $0.00 $0 D/D 11,100 17,616     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2021-02-16 4 S $48.87 $25,608 D/D (524) 6,516 20%     
   Taylor Michael Douglas Director   –       •      –    2021-02-01 4 AS $44.34 $361,872 D/D (8,000) 0 -23%     
   Taylor Michael Douglas Director   –       •      –    2021-02-01 4 OE $1.89 $15,120 D/D 8,000 8,000     -
   Hoerter Steven L. President and CEO   •       •      –    2021-01-21 4 OE $25.40 $27,381 D/D 1,078 43,845     -
   Bristol James Arthur Director   –       •      –    2021-01-15 4 AS $50.21 $352,039 D/D (7,000) 0 -32%     
   Bristol James Arthur Director   –       •      –    2021-01-15 4 OE $3.95 $27,650 D/D 7,000 7,000     -
   Taylor Michael Douglas Director   –       •      –    2021-01-04 4 AS $55.80 $1,072,497 D/D (19,000) 0 -42%     
   Taylor Michael Douglas Director   –       •      –    2021-01-04 4 OE $1.89 $35,910 D/D 19,000 19,000     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2020-12-09 4 OE $34.43 $7,127 D/D 207 37,418     -
   Taylor Michael Douglas Director   –       •      –    2020-12-01 4 AS $60.23 $1,157,142 D/D (19,000) 0 -28%     
   Taylor Michael Douglas Director   –       •      –    2020-12-01 4 OE $1.89 $35,910 D/D 19,000 19,000     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2020-11-16 4 OE $34.43 $92,858 D/D 2,697 37,211     -
   Taylor Michael Douglas Director   –       •      –    2020-11-04 4 AS $64.67 $971,987 D/D (15,000) 0 -32%     
   Taylor Michael Douglas Director   –       •      –    2020-11-04 4 OE $1.89 $28,350 D/D 15,000 15,000     -
   Taylor Michael Douglas Director   –       •      –    2020-11-02 4 AS $57.03 $1,343,926 D/D (23,315) 0 -26%     
   Taylor Michael Douglas Director   –       •      –    2020-11-02 4 OE $1.89 $44,065 D/D 23,315 23,315     -
   Bristol James Arthur Director   –       •      –    2020-10-09 4 AS $53.35 $1,261,069 D/D (23,541) 0 -22%     
   Bristol James Arthur Director   –       •      –    2020-10-09 4 OE $1.89 $44,492 D/D 23,541 23,541     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2020-10-02 4 D $51.15 $134,618 D/D (2,632) 34,128     -
   Taylor Michael Douglas Director   –       •      –    2020-10-01 4 AS $51.52 $6,450,484 D/D (125,000) 0 -5%     
   Taylor Michael Douglas Director   –       •      –    2020-10-01 4 OE $1.89 $236,250 D/D 125,000 125,000     -
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us